Ennis (NYSE: EBF) CFO adds options and boosts equity holdings
Rhea-AI Filing Summary
ENNIS, INC. CFO and Treasurer Vera Burnett reported routine equity compensation activity and updated holdings. She exercised derivative awards to acquire 1,802 shares of common stock at $0.0000 per share, bringing her direct common stock holdings to 29,608 shares. She also received an incentive stock option grant labeled “ISO granted 04/20/2026” covering 3,603 underlying common shares at an exercise price of $19.7600 per share.
Separately, a restricted stock unit award granted on 4/19/2024 was partially converted, covering 3,603 underlying common shares, leaving 3,605 RSU-related derivative units shown as outstanding. Burnett continues to hold incentive stock options granted on 4/21/2025 and 4/21/2023 with exercise prices of $17.2700 and $19.8800, respectively, covering 3,603 and 6,667 underlying common shares. She also has 1,214 common shares held indirectly through a Roth IRA.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | RSU granted 4/19/2024 | 3,603 | $0.00 | -- |
| Grant/Award | ISO granted 04/20/2026 | 3,603 | $19.76 | $71K |
| Exercise | Common Stock | 1,802 | $0.00 | -- |
| holding | ISO granted 4/21/2023 | -- | -- | -- |
| holding | ISO granted 4/21/2025 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Time-Based Restricted Units granted 4/19/2024 vest as follows: 1) thirty-three percent (33%) vest on April 21, 2025; 2) thirty-three percent (33%) vest on April 20, 2026; and 3) thirty-four percent (34%) vest on April 19, 2027. If the participant does not own Ennis common stock equal to value of 200% of the Participant's annual base salary at the time of each vesting date, then the time-based Subject Units vesting on that date shall vest as follows: fifty percent (50%) of the Time-Based Subject Units shall convert to incentive stock options with two incentive stock options issued for each Subject Unit. Option contract expires ten years from date of grant, and provides that shares will become exercisable 1/3 annually commencing on the first anniversary of grant. All option contracts are granted at market price on date of grant.